Filing Flows › Vaxart (VXRT) › Non Cash Royalty Revenue revenue
Vaxart (VXRT) Non Cash Royalty Revenue revenue by quarter
Vaxart's Non Cash Royalty Revenue revenue was $154K in Q3 2026 (third quarter 2026), up 14-fold from Q2 2026. Over the last 4 quarters it ranged from $11K (Q2 2026) to $1.6M (Q1 2025).
| Quarter | Non Cash Royalty Revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $154K | 14× | — |
| Q2 2026 | $11K | -74% | — |
| Q1 2026 | $42K | -97% | -97% |
| Q1 2025 | $1.6M | — | — |
Q3 2026 at a glance
Vaxart, Q3 2026: revenue $10.6M (-85% year over year), operating margin -162.7%, net loss $17.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Vaxart's Non Cash Royalty Revenue revenue?
Vaxart's Non Cash Royalty Revenue revenue was $154K in Q3 2026 (third quarter 2026), up 14-fold from Q2 2026.
How has Vaxart's Non Cash Royalty Revenue revenue changed?
Over the last 4 quarters it ranged from $11K (Q2 2026) to $1.6M (Q1 2025).